The global drug and gene delivery devices market size was exhibited at USD 438.36 billion in 2022 and is expected to hold around USD 815.06 billion by 2030 growing at a CAGR of 7.2% from 2022 to 2030.
The global drug and gene delivery devices market size was exhibited at USD 438.36 billion in 2022 and is expected to hold around USD 815.06 billion by 2030 growing at a CAGR of 7.2% from 2022 to 2030.
Drug and gene delivery includes the development of drugs, genes, and gene products and their delivery. It changes protein expression and cell functions. These devices are used in the treatment of genetic disorders. The delivery type includes nasal, oral, injectable, topical, ocular, transdermal, and inhalation. Drug and gene delivery uses ex vivo and in situ methods.
Get the Sample Copy of This Report@ https://www.precedenceresearch.com/sample/1388
Growth Factors
The rising prevalence of various chronic diseases and rapid technological advancements in drug delivery significantly contribute to the global drug and gene delivery devices market. The heavy investment by the market players in research and development activities in genomics positively influences market growth across the globe. In line with this, the shifting preferences of the patients catalyze the demand for drugs. The launch of auto-injectors and adaptive aerosol delivery systems creates a positive outlook for the market. The increasing awareness about the ability of drugs to treat chronic diseases propels market growth. The rapid adoption of gene therapeutics favors market growth. Factors such as the availability of new drugs and heavy investments in the development of new drugs significantly contribute to market growth across the globe. The considerable growth of the biopharmaceutical industry across the globe drives market growth. The presence of numerous market players boosts overall market growth. Various strategies adopted by the leading players, such as product launches, acquisitions, mergers, and partnerships, create a positive outlook for the market. The increasing demand for drug and gene delivery devices catalyzes market growth worldwide. Furthermore, the formulation of dosage forms and the introduction of novel drug delivery systems drive market growth. Apart from this, patients’ and physicians’ changing preferences significantly contribute to the market growth. The growing requirement for injectable medications drives market expansion.
Drug and gene delivery devices Market Report Scope
| Report Coverage | Details |
| Market Size In 2022 | USD 438.36 Billion |
| Market Size By 2030 | USD 815.06 Billion |
| Growth Rate From 2022 to 2030 | CAGR of 7.2% |
| Base Year | 2021 |
| Forecast Period | 2022 to 2030 |
| Segments Covered |
|
| Regions Covered |
|
Report Highlights:
- Based on delivery type, the oral dominated the market and accounted for the largest revenue share. It’s expected to maintain its dominance in the coming years. Oral drug delivery is becoming very famous across the globe. It is the most convenient route of administration. It is a self-administered type of delivery and is pain-free. The development of various therapeutics that can treat the affected cell boosts segment growth. The rapid growth of gene therapies, biosimilar, and targeted therapeutics, drives the segment’s growth. On the other hand, the injectable is expected to witness a promising CAGR in the coming years. This is due to rapid technological advancements and the rising number of diabetic populations. The increasing popularity of auto-injectors positively influences market growth. It helps people to conveniently administer drugs at their homes. All these factors are expected to catalyze segment growth.
- Based on the method, the in situ dominated the market and accounted for the largest revenue share. It offers various benefits like ease of drug administration and less complexity in fabrication.
- Based on vectors, viral vectors dominated the market and accounted for the largest revenue share. The clinical trials on gene therapies employ viral vectors for transfection. It helps in improving the success rate of gene transfer.
Ask Here for Customization@ https://www.precedenceresearch.com/customization/1388
Regional Snapshots
Based on region, North America dominated the market and accounted for the largest revenue share. It’s expected to maintain its dominance in the coming years. This is due to the increasing incidence of chronic conditions. More than 60% of the people in the USA suffer from at least one chronic disease. Besides, the launch of therapeutics and innovative drugs significantly contributes to market growth across the region. These drugs help in effectively treating chronic diseases and genetic diseases. Moreover, the growing demand for personalized medicines boosts the overall market growth.
Asia Pacific is expected to witness a promising CAGR in the coming years. This is due to the rising prevalence of various chronic diseases and significant growth in the biopharmaceutical industry. The emergence of new market players positively influences market growth across the region.
Market Dynamics:
Driver: Increasing prevalence of chronic disorders
The rising prevalence of chronic disorders is driving market growth across the globe. In line with this, the increasing geriatric population who are susceptible to these chronic conditions significantly contributes to the market growth worldwide. Furthermore, there has been a growing number of people suffering from diabetes and cancer. The rapid growth of these diseases facilitates the drug and gene delivery devices market growth. The presence of a large number of key market players positively influences market growth worldwide. The market players are developing advanced gene delivery systems and drug development.
Opportunity: Rising Shift of Patients towards Advanced Drug Delivery Systems
The rising shift of patients towards advanced drug delivery systems offers numerous opportunities for market growth. In line with this, the increasing demand for advanced products significantly contributes to market growth. These sophisticated products are capable of delivering a drug to a specific required area. The rising popularity of self-administered devices among patients propels market growth. The growing awareness of advanced products catalyzes market growth. The increasing government initiatives for raising public awareness of the products strengthen the market growth.
Restraint: Stringent Regulations
The major factor restricting the drug and gene delivery devices market is stringent government regulations. The regulations are associated with the sanction of drug delivery devices. The product recalls further hampers the market growth.
Challenge: High costs of research and development activities
The high costs of research and development activities challenge market growth. In line with this, limited infrastructural facilities further hamper the growth of the market. Furthermore, the lack of a favorable reimbursement scenario impeded market growth. Moreover, the availability of low-cost substitutes is expected to challenge the drug and gene delivery devices market growth.
Related Reports
- Non-Invasive Blood Glucose Monitoring System Market 2022 To 2030
https://www.precedenceresearch.com/non-invasive-blood-glucose-monitoring-system-market
- Dermatology CRO Market 2022 Toi 2030
https://www.precedenceresearch.com/dermatology-cro-market
- Breast Biopsy Devices Market 2022 To 2030
https://www.precedenceresearch.com/breast-biopsy-devices-market
Key Developments:
- In June 2022, Roche launched Human papillomavirus (HPV) self-sampling equipment. It helps in identifying women who are at risk of having cervical cancer.
Major Key Players
- Pfizer, Inc.
- F. Hoffmann-La Roche Ltd
- Johnson and Johnson Private Ltd
- Novartis AG
- Bayer AG
- Becton, Dickinson and Company
- Uniqure NV
Market Segmentation
By Delivery Type
- Oral
- Ocular
- Inhalation
- Nasal
- Injectable
- Transdermal
- Topical
By Method
- In Situ
- Ex Vivo
By Vector
- Viral Vector
- Non-Viral Vector
Regional Segmentation
- North America (U.S., Canada, Mexico)
- Europe (Germany, France, U.K., Italy, Spain, Rest of Europe)
- Asia-Pacific (China, Japan, India, Southeast Asia and Rest of APAC)
- Latin America (Brazil and Rest of Latin America)
- Middle East and Africa (GCC, North Africa, South Africa, Rest of MEA)
https://www.precedenceresearch.com/table-of-content/1388
Thanks for reading you can also get individual chapter-wise sections or region-wise report versions such as North America, Europe, or the Asia Pacific.
Immediate Delivery Available | Buy This Premium Research Report@ https://www.precedenceresearch.com/checkout/1388
You can place an order or ask any questions, please feel free to contact at sales@precedenceresearch.com | +1 9197 992 333